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ABSTRACT 
Background: There is little information regarding the determinants and trends of the prevalence of low cardiovascular risk factor (RF) profile in the general population. The aim of this study was to assess the prevalence and trends of low RF profile in the Swiss population according to different definitions.  
Methods: Population-based cross-sectional studies conducted in 1984-6 (N=3300), 1988-9 (N=3331), 1992-3 (N=3133) and 2003-6 (N=6170) and restricted to age group 35-75 years. Seven different definitions of low RF profile were used to assess determinants, while two definitions were used to assess trends. 
Results: Prevalence of low RF profile varied between 6.5% (95% confidence interval: 5.9-7.1) and 9.7% (9.0-10.5) depending on the definition used. This prevalence was higher than in other countries. Irrespective of the definition used, the prevalence of low RF profile was higher in women and in physically active participants, and decreased with increasing age or in the presence of a family history of cardiovascular disease. Using one definition, the prevalence of low RF profile increased from 3.8% (3.1-4.5) in 1984-6 to 6.7% (6.1-7.3) in 2003-6; using another definition, the results were 5.9% (5.1-6.8) and 9.7% (9.0-10.5), respectively. 
Conclusion: Switzerland is characterized by a high and increasing prevalence of low RF profile within the age group 35 to 75, irrespective of the criteria used. This high prevalence might partly explain the low and decreasing trend in cardiovascular mortality rates. 
 
Keywords: epidemiology; cardiovascular risk factors; low risk; Switzerland; population sample. 
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INTRODUCTION Cardiovascular Diseases (CVD) are one of the most important causes of death worldwide, with considerable human and financial consequences. While most epidemiological research has focused on high-risk subjects, some authors focused on the other side of the CVD risk spectrum, i.e. on subjects with a low RF profile, characterized by the absence of CVD risk factors, or even presence of favorable CVD “benefic” factors such as a healthy diet or regular physical activity [1-3]. These low RF subjects present with a very low risk of developing CVD [2, 4-6], but comparisons between studies are difficult as several definition of the low RF profile exist [1-11], which might lead to differing, non-comparable prevalences. Finally, little if no information exists regarding the trends in the prevalence of low RF profile in the general population.  Hence, we used the data from a large, population-based cohort of subjects aged 35 to 75 years to assess 1) the prevalence of low RF subjects according to different definitions and 2) the 20-year trends in the prevalence of selected definitions of low RF subjects by comparing our results with those obtained from the MONICA population surveys conducted between 1984 and 1993, again limited to the age group 35-75. 
METHODS 
The CoLaus study The sampling procedure of the Cohorte Lausannoise (CoLaus) study has been described previously [12]. Briefly, the complete list of the Lausanne inhabitants aged 35–75 years (n=56 694) was provided by the population registry of the city and a simple, nonstratified random sample of 35% was drawn. An invitation letter with a quick 
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description of the study was sent to all randomized participants. Individuals interested were contacted telephonically within 14 days by one of the staff members who provided more information about the study and arranged for an appointment. As the CoLaus study aimed at including only Caucasians to avoid population stratification and to increase genetic homogeneity for association studies, the following inclusion criteria were applied: (i) written informed consent; (ii) age 35–75 years; (iii) willingness to take part in the examination and to have a blood sample drawn and (iv) Caucasian origin, defined as having both parents and grandparents of Caucasian origin. Recruitment began in June 2003 and ended in May 2006. Participation rate was 41% and 6,188 Caucasian participants (3,251 women and 2,937 men) took part in the study. 
Risk factor assessment, CoLaus All participants attended the outpatient clinic of the University Hospital of Lausanne in the morning after an overnight fast (minimum fasting time 8 hours). Data were collected by trained field interviewers in a single visit lasting about 60 min. Participants received a questionnaire to record information about their lifestyle factors. According to their smoking histories, participants were classified as never, current or former smokers. During a face-to-face meeting, the participants were asked if they or their parents had presented CVD. Personal history of and current treatment for hypertension, hypercholesterolemia or diabetes were also asked. Information on the use of prescription and over the counter drugs, vitamin and mineral supplements, homeopathy or natural remedies was collected, together with their main indications. Collection was done by asking the participant to bring the drugs to the visit. Physical activity was defined as the practice of leisure time physical activity at least twice per week. 
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Body weight and height were measured in light indoor clothes with shoes off. Body weight was measured in kilograms to the nearest 100g using a Seca® scale, which was calibrated regularly. Height was measured to the nearest 5 mm using a Seca® height gauge. Body Mass Index (BMI) was calculated as weight (kg) divided by the square of the height (m). Overweight was defined as BMI ≥25 kg/m 2 and <30 kg/m2, and obesity by a BMI ≥30 
kg/m2. Blood pressure was measured on the left arm, with an appropriately sized cuff, after at least 10 minute rest in the seated position using an Omron® HEM-907 automated oscillometric sphygmomanometer. Three readings were taken and the average of the last two was used to compute systolic (SBP) and diastolic (DBP) blood pressure. 
Fasting plasma glucose and total cholesterol levels were measured by the CHUV Clinical Laboratory on fresh blood samples within 2 hours of blood collection. All measurements were conducted in a Modular P apparatus (Roche Diagnostics, Switzerland). The following analytical procedures (with maximum inter and intra-batch CVs) were used: glucose by glucose dehydrogenase (2.1% – 1.0%) and total cholesterol by CHOD-PAP (1.6% – 1.7%). 
MONICA population surveys The MONICA Project (Multinational MONItoring of trends and determinants in CArdiovascular disease)[13, 14] was created in the early 1980s in different centers around the world to monitor over a ten year period trends in cardiovascular disease mortality and incidence. Thirty-one collaborating centers (25 from Europe, one from Canada, one from the US, two from Australia, one from New Zealand and one from China) took part in the 
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project. In each population, investigators had to satisfy the local requirements for ethical research [14]. 
In this study, we used the data from the three Swiss MONICA population surveys conducted in the Vaud and Fribourg cantons for the periods 1984-6, 1988-9 and 1992-3. Their main characteristics have been published previously [15]. The initial samples included participants aged between 25 and 75, but in order to be comparable with the CoLaus study we restricted the analysis to participants aged between 35 and 75 years. 
Risk factor assessment, MONICA Body weight and height were measured with participants standing without shoes and heavy outer garments and with empty pockets. Blood samples from non-fasting subjects were used to measure the total cholesterol (TC). Smoking status was initially divided in 4 categories, daily cigarette smokers, non smokers, ex-smokers and “different types” of smokers (occasional, pipe, cigars). For the current analysis, daily and “different types” of smokers were grouped. 
The authors of this manuscript have certified that they comply with the Principles of Ethical Publishing in the International Journal of Cardiology [16]. 
Low risk factor profile A literature search on Pubmed using the terms “low cardiovascular risk”, “low risk factor”, “favorable risk factor” in association or not with the words “prevalence” and “epidemiology” revealed eleven different definitions for low RF profile [1-11]. Their criteria are summarized in supplementary table 1. Three major CVD risk factors were common to 
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all definitions: blood pressure (SBP <120 and DBP <80 mm Hg); smoking (absence) and 
total cholesterol (<200 mg/dL (<5.2 mmol/L)); for total cholesterol, only Yamamoto used a different threshold: 160-240 mg/dL (4.14-6.22 mmol/L). Additional criteria differed according to each author. Most authors also included antihypertensive medication 
(absence), personal history of diabetes (absence) and BMI (<25 kg/m2) in their criteria. Three studies included electrocardiographic findings, two cholesterol lowering drug treatment and one included personal history of myocardial infarction. Fasting plasma glucose level was a criterion in one study and lifestyle (physical activity and diet) in another. Overall, the number of criteria used to define low RF profile varied between 4 and 11. Noteworthy, a single author (Daviglus) used slightly different sets of criteria to define low RF profile [1, 4, 7, 8] (table 1). The prevalence of low RF profile in the CoLaus cohort was computed using the following sets of criteria: Daviglus 2 [7] and 3 [4], Hozawa [5], 
Yamamoto [3], Giampaoli [2], Stamler [6] and Lowe [9] as they included data available in the CoLaus study. The sets of criteria Daviglus 1 [1] and Daviglus 4 [8] were not retained due to the lack of ECG data and the sets of criteria of Folsom [10] and Mozaffarian [11] were not retained due to the lack of physical activity and dietary data. Similarly, due to limitation in variables from the MONICA surveys, only two sets of criteria were used to assess trends in the prevalence of low RF profile: Lowe (SBP <120 mmHg, DBP <80 mmHg, total 
cholesterol <200 mg/dl, no smoking) [9] and Daviglus 2 (SBP <120 mmHg, DBP <80 mmHg, total cholesterol <200 mg/dl, no smoking, no use of antihypertensive medication, BMI <25 
kg/m2) [7]. 
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Statistical analysis Statistical analyses were made using Stata v.11.1 (Stata Corp, College Station, TX, USA). The prevalence of participants with low RF profile was determined for each set of criteria and expressed in percentage and (95% confidence interval). Between-group comparisons were performed using Chi-square for qualitative variables or Student’s t-test for quantitative variables. Multivariate analysis modeling the likelihood of presenting with low RF profile was conducted using logistic regression adjusting for gender, age and physical activity and the results were expressed as odds ratio (OR) and (95% confidence interval). Standardized estimates of the prevalence of low risk profile were obtained by direct standardization using the Standard European Population as defined by [17]. Statistical significance was considered for p<0.05. 
RESULTS 
Characteristics of the subjects Of the initial 6188 participants, 6170 (99.7%, 3241 women and 2929 men) had data for all variables and were included in the analysis. Table 1 summarizes their clinical characteristics according to gender. Overall, women had a lower BMI, blood pressure and fasting plasma glucose than men, women also smoked less, practiced more physical activity and had less history of MI and CVD than men. Finally, women had higher total and HDL cholesterol levels than men (table 1). 
Prevalence and trends of low risk factor profile The prevalence of low RF profile overall and according to different characteristics is summarized in table 2. Women had a higher prevalence of a low risk profile; physical 
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activity was positively associated with low risk, while increasing age, family history of CVD, stroke or MI were associated with a lower prevalence of low RF profile. These findings were further confirmed by multivariate logistic regression adjusting for gender, age and leisure-time physical activity, where subjects with a family history of CVD (coronary heart disease or stroke) had a lower likelihood of presenting with low RF profile: odds-ratios (95% confidence interval) ranging from 0.76 (0.60-0.96) to 0.81 (0.62-1.04). The results were comparable (odds-ratio below 1) for coronary heart disease and stroke taken individually, but did not reach statistical significance (table 3). The trends in the prevalence of low RF profile for period 1984-2006 are summarized in table 4. The prevalence of low RF profile remained rather stable between 1984 and 1993 and increased afterwards. Interestingly, the prevalence of low RF profile in the MONICA studies showed the same pattern of associations (higher in women and lower among older participants). In the CoLaus study, the prevalence of low RF in men and women was higher than in the other studies (table 5). 
DISCUSSION 
 To our knowledge, this is the first ever study to compare the results of different definitions of low RF profile in the same population. Our results suggest that the prevalence of low RF profile is rather low and depends on the number of criteria used, as the two studies using the fewest criteria (Lowe and Hozawa) led to the highest prevalence. This is understandable, as the probability of fulfilling all criteria decreases with the number of criteria used. Still, and even more important than the number of criteria used, the age of the participant was the main factor to influence the prevalence of low RF profile. This finding is 
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in agreement with the literature [18], as it has been shown that CVD risk increases with age, in association with a decrease in the number of normal or optimal level RFs. Overall, our results indicate that the more criteria to define low RF profile or the higher the age of the participants, the lower the prevalence of low RF profile. The prevalence of low RF profile was higher in CoLaus than in the other studies. Only the studies by Daviglus (set 3) [4] and Yamamoto [3] had a higher prevalence of low RF profile among women. This finding can be explained by the younger age of the participants in both surveys: in the American study, mean (± SD) age was 31.0 ± 1.3 years, vs. 53.5 ± 10.7 years in the CoLaus study; in the Japanese study, the age range was 30-69 years, vs. 35-75 years in the CoLaus study. Interestingly, restricting the analysis in the CoLaus study to the 30-69 years age group led to a higher prevalence of low RF profile in women (9.7%) albeit lower than in the Japanese study. One possible explanation might be related to the fact that Asians tend to present with lower BMI levels [19] and probably also with a lower prevalence of CVD risk factors. Overall, our results indicate that, compared to other studies, the prevalence of low RF profile is relatively high in this Swiss population-based sample. This high prevalence of low RF profile among the Swiss might partly explain the low CVD mortality rates observed in Switzerland relative to the other countries [20]. The trends in the prevalence of low RF profile in the Swiss population were assessed using data from the MONICA population studies and the criteria of Daviglus (set 2) [7] and Lowe [9]. The results suggest that the prevalence of low RF profile was stable between 1984 and 1993 and increased afterwards (table 4). This favorable change could be due to changes in a single or several risk factor(s), such as smoking (increase in the nineties and decrease afterwards) [21], physical activity (increase) [22] or the maintenance of a 
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relatively healthy diet [23]. Indeed, in the CoLaus study, the prevalence of low RF profile was higher among participants who practiced leisure physical activity; conversely, no dietary data was available to confirm the last hypothesis. Finally, this increase in the prevalence of low RF profile is in agreement with the decrease in CVD mortality rates observed in Switzerland [24]. Overall, our results indicate that the prevalence of low RF profile is increasing in Switzerland, and that this increase could be due to changes in several RF such as smoking or physical activity, or the maintenance of a healthy diet. Participants with a family history of cardiovascular disease had a lower likelihood of presenting with a low RF profile. This finding was further confirmed by multivariate adjustment, although the association did not reach statistical significance for coronary heart disease or stroke taken individually, probably due to the small sample size. This finding could partly be explained by worse dietary behaviors or a particular genetic background. The existence of a large genetic database for most of the CoLaus participants and the ongoing follow-up of the entire cohort (which also includes dietary assessment) will allow a better assessment of these hypotheses. This study has some limitations. First, generalization might be limited by the modest participation rate (41%), but this rate is comparable to other epidemiological studies [25]. Second, it is possible that the CoLaus participants are more health-conscious than the general population, thus biasing the observed prevalences of the low RF profile to higher than actual values; still, all studies which assessed low RF profile did so using volunteers, so this overestimation bias also applies to them. Third, the CoLaus study only included Caucasian participants, and it has been suggested that the prevalence of low RF profile is higher in non-Caucasian populations [5, 26]. Still, most studies which assessed low RF 
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profile included mostly white, Caucasian participants [2, 6], with the exception of Daviglus [1, 4, 7, 8], Folsom [10] and Lowe [9], so comparison of our results with these studies can still be performed. Finally, it might be questioned whether the CoLaus study is representative of the Swiss population; still, a considerable fraction of the Lausanne inhabitants are actually not native to the Vaud canton: in 2006, out of the 128,231 Lausanne inhabitants, 49,330 (38%) were non-Swiss, 38,513 (30%) came from other cantons, and only 40,388 subjects (32%) were from the Vaud canton. Hence, we do believe that the CoLaus study represents a fairly good sample of the Swiss population. Finally, as the CoLaus study only included participants aged between 35 and 75, the prevalence rates provided only apply to the population within this age range. As the prevalence of low risk profile is dependent on age, younger or older age groups would have higher and lower prevalence rates, respectively. 
CONCLUSION Our results indicate that, in a given population, the prevalence of low cardiovascular risk factor profile varies according to the criteria used. Compared to other countries, the prevalence of low cardiovascular risk factor profile is relatively high and increasing in the Swiss population, which might partly explain the low and decreasing trend in cardiovascular mortality rates. 
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TABLES 
Table 1: clinical characteristics of the sample, by gender 
 Women Men P-value Overweight (%) 28.3 45.5 <0.001 Obese (%) 14.3 16.9  Current smoker (%) 24.9 29.2 <0.001 Systolic blood pressure (mm Hg) 125 ± 18 132 ± 17 <0.001 Diastolic blood pressure (mm Hg) 78 ± 11 81 ± 11 <0.001 
Total cholesterol (mmol/L) 5.61 ± 1.03 5.56 ± 1.04 <0.05 HDL cholesterol (mmol/L) 1.81 ± 0.43 1.44 ± 0.36 <0.001 
Fasting plasma glucose (mmol/L) 5.34 ± 1.02 5.78 ± 1.23 <0.001 Physical activity (%) § 57.3 53.5 <0.001 Baseline CVD (%) 5.2 7.9 <0.001  Results are expressed as mean ± standard deviation or as number of participants and (percentage). § defined as the practice of leisure time physical activity at least twice per week. BMI, body mass index; CVD, Cardiovascular Disease; HDL, high density lipoprotein; MI, Myocardial Infarction. Statistical analysis by Chi-square or Student’s t-test.  
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Table 2: Prevalence of low risk, by clinical characteristics 
 Daviglus 2 
[7] 
Daviglus 3 
[4] 
Hozawa 
[5] 
Yamamoto 
 [3] 
Giampaoli 
[2] 
Stamler 
[6] 
Lowe 
[9] Prevalence (%) 6.7 (6.1 – 7.3) 6.5 (5.9 – 7.1) 9.4 (8.7 – 10.2) 7.0 (6.4 – 7.7) 6.6 (6.0 – 7.2) 9.3 (8.5 – 10.0) 9.7 (9.0 – 10.5) By gender (%)        Women 9.6 (8.6 – 10.6) 9.4 (8.4 – 10.4) 12.7 (11.6– 13.9) 9.1 (8.1 – 10.1) 9.5 (8.5 – 10.5) 12.7 (11.5– 13.8) 12.9 (11.8– 14.1) Men 3.5 (2.8 – 4.1) 3.2 (2.5 – 3.8) 5.7 (4.9 – 6.6) 4.8 (4.0 – 5.5) 3.4 (2.7 – 4.0) 5.5 (4.6 – 6.3) 6.1 (5.2 – 7.0) P-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 By age group (%)        [35 – 44] 15.0 (13.3-16.7) 14.8 (13.1– 16.5) 19.7 (17.8– 21.6) 9.4 (8.0 – 10.7) 14.8 (13.1– 16.5) 19.6 (17.8– 21.5) 20.0 (18.2– 21.9) [45 – 54] 6.5 (5.4 – 7.7) 6.2 (5.1 – 7.3) 9.3 (8.0 – 10.7) 8.5 (7.2 – 9.8) 6.4 (5.3 – 7.6) 9.2 (7.8 – 10.5) 9.6 (8.2 – 10.9) [55 – 64] 1.9 (1.2 – 2.5) 1.7 (1.0 – 2.3) 3.4 (2.5 – 4.3) 5.9 (4.8 – 7.0) 1.8 (1.2 – 2.5) 3.2 (2.3 – 4.0) 3.7 (2.8 – 4.5) [65 – 75] 0.5 (0.1 – 0.10) 0.3 (0.0 – 0.7) 1.7 (0.8 – 2.5) 2.2 (1.2 – 3.1) 0.5 (0.1 – 1.0) 1.4 (0.1 – 2.2) 2.0 (1.1 – 2.8) P-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 Physical activity (%)        
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No 5.2 (4.3 – 6.0) 5.0 (4.2 – 5.8) 8.0 (7.0 – 9.0) 5.1 (4.3 – 5.9) 5.1 (4.2 – 5.9) 7.8 (6.8 – 8.8) 8.4 (7.3 – 9.4) 
Yes 7.9 (7.0 – 8.8) 7.6 (6.7 – 8.5) 10.6 (9.5 – 11.6) 8.6 (7.6 – 9.5) 7.8 (6.9 – 8.7) 10.4 (9.4 – 11.4) 10.7 (9.7 – 11.8) P-value <0.001 <0.001 <0.002 <0.001 <0.001 <0.002 <0.005 Family history of CHD (%)        No 7.0 (6.3 – 7.8) 6.8 (6.1 – 7.5) 9.9 (9.1 – 10.7) 7.3 (6.5 – 8.0) 6.9 (6.2 – 7.6) 9.7 (8.9 – 10.6) 10.2 (9.4 – 11.1) 
Yes 5.3 (4.1 – 6.6) 5.0 (3.8 – 6.2) 7.5 (6.1 – 9.0) 6.1 (4.8 – 7.4) 5.3 (4.1 – 6.6) 7.4 (5.9 – 8.8) 7.7 (6.2 – 9.2) P-value <0.05 <0.05 <0.05 <0.20 <0.05 <0.01 <0.01 Family history of stroke (%)        No 7.1 (6.4 – 7.8) 6.9 (6.2 – 7.6) 10 (9.1 – 10.8) 7.1 (6.4 – 7.8) 7.0 (6.3 – 7.7) 9.8 (9.0 – 10.6) 10.2 (9.4 – 11.1) 
Yes 4.4 (3.1 – 5.7) 4.0 (2.7 – 5.2) 6.5 (4.9 – 8.1) 6.5 (4.9 – 8.1) 4.4 (3.1 – 5.7) 6.3 (4.7 – 7.8) 6.7 (5.1 – 8.3) P-value <0.005 <0.005 <0.005 <0.50 <0.005 <0.002 <0.002 Family history of CVD (%)        No 7.5 (6.6 – 8.3) 7.3 (6.5 – 8.1) 10.4 (9.5 – 11.4) 7.5 (6.7 – 8.3) 7.4 (6.6 – 8.1) 10.3 (9.4 – 11.2) 10.7 (9.8 – 11.7) 
Yes 5.0 (4.1 – 6.0) 4.7 (3.8 – 5.6) 7.3 (6.2 – 8.5) 6.1 (5.1 – 7.2) 5.0 (4.1 – 6.0) 7.1 (6.0 – 8.3) 7.5 (6.4 – 8.7) P-value <0.001 <0.001 <0.001 <0.06 <0.002 <0.001 <0.001 Results are expressed as percentage. Statistical analysis by Chi-square. 
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Table 3: multivariate analysis of the likelihood of presenting with a low cardiovascular risk factor profile according to presence or absence of a family history of cardiovascular disease. 
Family history of Daviglus 2 Daviglus 3 Hozawa Yamamoto Giampaoli Stamler Lowe Coronary heart disease 0.77 (0.58 - 1.02) 0.75 (0.56 - 1.00) 0.77 (0.60 - 0.97) 0.81 (0.62 - 1.04) 0.79 (0.59 - 1.04) 0.76 (0.60 - 0.97) 0.76 (0.60 - 0.96) Stroke 0.78 (0.55 - 1.10) 0.73 (0.51 - 1.04) 0.79 (0.60 - 1.05) 0.95 (0.72 - 1.26) 0.80 (0.56 - 1.12) 0.78 (0.59 - 1.04) 0.79 (0.60 - 1.05) Cardiovascular disease 0.77 (0.61 - 0.99) 0.74 (0.58 - 0.95) 0.79 (0.64 - 0.97) 0.82 (0.65 - 1.02) 0.79 (0.62 - 1.01) 0.78 (0.64 - 0.96) 0.79 (0.64 - 0.96)  Results are expressed as odds-ratio and (95% confidence interval) for presence vs. absence of family history. Statistical analysis conducted independently for each condition by logistic regression adjusting for gender, age and physical activity. The significant results have a grey background.  
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Table 4: Evolution of the prevalence of low risk profile in several population-based studies in Switzerland, 1984-2006. 
 Daviglus 2 Lowe  1984-6 1988-9 1992-3 2003-6 1984-6 1988-9 1992-3 2003-6 Prevalence (%) 3.8 (3.1 - 4.5) 3.3 (2.6 - 3.9) 3.7 (3.0 - 4.4) 6.7 (6.1 - 7.3) 5.9 (5.1 - 6.8) 4.4 (3.7 - 5.2) 5.0 (4.2 - 5.8) 9.7 (9.0 - 10.5) By gender (%)         Women 6.1 (4.9 - 7.4) 5.1 (3.9 - 6.2) 5.9 (4.6 - 7.1) 9.6 (8.6 - 10.6) 8.5 (7.1 – 10.0) 6.3 (5.0 - 7.6) 7.6 (6.2 - 8.9) 12.9 (11.8 - 14.1) Men 1.5 (0.9 - 2.1) 1.6 (0.9 - 2.2) 1.4 (0.7 - 2.0) 3.5 (2.8 - 4.1) 3.4 (2.5 - 4.3) 2.6 (1.8 - 3.5) 2.3 (1.5 - 3.1) 6.1 (5.2 - 7.0) By age group (%)         [35 – 44] 7.0 (5.5 - 8.5) 6.8 (5.2 - 8.4) 7.6 (6.0 - 9.3) 15.0 (13.3 - 16.7) 10.7 (8.9 - 12.5) 8.7 (7.0 - 10.5) 9.7 (7.8 - 11.6) 20.0 (18.2 - 21.9) [45 – 54] 2.6 (1.5 - 3.6) 2.2 (1.2 - 3.1) 2.6 (1.6 - 3.7) 6.5 (5.4 - 7.7) 4.3 (3.0 - 5.7) 3.5 (2.3 - 4.7) 3.9 (2.7 - 5.2) 9.5 (8.2 - 10.9) [55 – 64] 1.3 (0.5 - 2.2) 0.6 (0.0 - 1.1) 0.3 (0.0 - 0.7) 1.9 (1.2 - 2.5) 2.2 (1.1 - 3.3) 0.8 (0.2 - 1.5) 0.7 (0.1 - 1.4) 3.6 (2.8 - 4.5) [65 – 75] 0.0 0.4 (0.0 - 1.3) 0.5 (0.0 - 1.6) 0.5 (0.1 - 1.0) 0.0 0.4 (0.0 - 1.3) 1.1 (0.0 - 2.6) 2.0 (1.1 - 2.8) Standardized prevalence 3.2 (2.3 - 4.2) 2.9 (1.9 - 4.0) 3.3 (2.3 - 4.4) 7.1 (6.0 - 8.2) 5.1 (3.9 - 6.3) 4.0 (2.9 - 5.2) 4.5 (3.1 - 5.8) 10.1 (8.9 - 11.5)  
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Results are expressed as percentage and (95% confidence interval). The standardized prevalence of low risk profile was obtained by direct standardization using the Standard European Population as defined by [17]. 
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Table 5: Comparison of the prevalence of low risk factor profile between the current study and other studies, using the same criteria to define low risk profile. 
Prevalence rates Daviglus 2 Daviglus 3 Hozawa Yamamoto Giampaoli Stamler Lowe This study (%)        Overall 6.7 (6.1 – 7.3) 6.5 (5.9 – 7.1) 9.4 (8.7 – 10.2) 7.0 (6.4 – 7.7) 6.6 (6.0 – 7.2) 9.3 (8.5 – 10.0) 9.7 (9.0 – 10.5) Women 9.6 (8.6 – 10.6) 9.4 (8.4 – 10.4) 12.7 (11.6– 13.9) 9.1 (8.1 – 10.1) 9.5 (8.5 – 10.5) 12.7 (11.5– 13.8) 12.9 (11.8– 14.1) Men 3.5 (2.8 – 4.1) 3.2 (2.5 – 3.8) 5.7 (4.9 – 6.6) 4.8 (4.0 – 5.5) 3.4 (2.7 – 4.0) 5.5 (4.6 – 6.3) 6.1 (5.2 – 7.0) Original study (%)        Period of inclusion 1967 – 1973 1967 – 1973 1987 – 1989 1980 1983 – 1997 1967 – 1975 1967 – 1973 Age range (years) 40 – 59 18 – 39 45 – 64 30 – 69 35 – 69 35 – 59 § 40 – 64 Women 4.7 20.1 6.5 14.4 3.5  6.6 Men 2.0  4.6 3.0 1.6  4.8  § pooled data from two cohorts
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Background: There is little information regarding the determinants and trends of the prevalence of low cardiovas-
cular risk factor (RF) proﬁle in the general population. The aim of this studywas to assess the prevalence and trends
of low RF proﬁle in the Swiss population according to different deﬁnitions.
Methods: Population-based cross-sectional studies conducted in 1984–1986 (N=3300), 1988–1989 (N=3331),
1992–1993 (N=3133) and 2003–2006 (N=6170) and restricted to age group 35–75 years. Seven different deﬁni-
tions of low RF proﬁle were used to assess determinants, while two deﬁnitions were used to assess trends.
Results: Prevalence of low RF proﬁle varied between 6.5% (95% conﬁdence interval: 5.9–7.1) and 9.7% (9.0–10.5)
depending on the deﬁnition used. This prevalence was higher than in other countries. Irrespective of the deﬁnition
used, the prevalence of low RF proﬁle was higher in women and in physically active participants, and decreased
with increasing age or in the presence of a family history of cardiovascular disease. Using one deﬁnition, the prev-
alence of low RF proﬁle increased from 3.8% (3.1–4.5) in 1984–1986 to 6.7% (6.1–7.3) in 2003–2006; using another
deﬁnition, the results were 5.9% (5.1–6.8) and 9.7% (9.0–10.5), respectively.
Conclusion: Switzerland is characterized by a high and increasing prevalence of low RF proﬁle within the age group
35 to 75, irrespective of the criteria used. This high prevalencemight partly explain the low and decreasing trend in
cardiovascular mortality rates.© 2012 Published by Elsevier Ireland Ltd.1. Introduction
Cardiovascular diseases (CVD) are one of the most important
causes of death worldwide, with considerable human and ﬁnancial
consequences. While most epidemiological research has focused on
high-risk subjects, some authors focused on the other side of the
CVD risk spectrum, i.e. on subjects with a low RF proﬁle, characterized
by the absence of CVD risk factors, or even presence of favorable CVD
“beneﬁc” factors such as a healthy diet or regular physical activity
[1–3]. These low RF subjects present with a very low risk of develop-
ing CVD [2,4–6], but comparisons between studies are difﬁcult as sev-
eral deﬁnitions of the low RF proﬁle exist [1–11], which might lead to
differing, non-comparable prevalence. Finally, little if no information
exists regarding the trends in the prevalence of low RF proﬁle in the
general population.
Hence, we used the data from a large, population-based cohort of
subjects aged 35 to 75 years to assess (1) the prevalence of low RF
subjects according to different deﬁnitions and (2) the 20-year trendsgrants fromGlaxoSmithKline,
erland and the Swiss National
édecine Sociale et Préventive,
nne, Switzerland. Tel.: +41 21
.ch (P. Marques-Vidal).
sevier Ireland Ltd.
ho is at low risk for cardiov
012.07.004in the prevalence of selected deﬁnitions of low RF subjects by com-
paring our results with those obtained from the MONICA population
surveys conducted between 1984 and 1993, again limited to the age
group 35–75.
2. Methods
2.1. The CoLaus study
The sampling procedure of the Cohorte Lausannoise (CoLaus) study has been described
previously [12]. Brieﬂy, the complete list of the Lausanne inhabitants aged 35–75 years (n=
56 694)was provided by the population registry of the city and a simple, non‐stratiﬁed ran-
dom sample of 35%was drawn. An invitation letterwith a quick description of the studywas
sent to all randomized participants. Individuals interested were contacted telephonically
within 14 days by one of the staff members who provided more information about the
study and arranged for an appointment. As the CoLaus study aimed at including only Cauca-
sians to avoid population stratiﬁcation and to increase genetic homogeneity for association
studies, the following inclusion criteria were applied: (i) written informed consent; (ii) age
35–75 years; (iii) willingness to take part in the examination and to have a blood sample
drawn and (iv) Caucasian origin, deﬁned as having both parents and grandparents of Cauca-
sian origin. Recruitment began in June 2003 and ended in May 2006. Participation rate was
41% and 6188 Caucasian participants (3251 women and 2937 men) took part in the study.
2.2. Risk factor assessment, CoLaus
All participants attended the outpatient clinic of the University Hospital of Lausanne in
the morning after an overnight fast (minimum fasting time 8 h). Data were collected by
trained ﬁeld interviewers in a single visit lasting about 60 min.
Participants received a questionnaire to record information about their lifestyle
factors. According to their smoking histories, participants were classiﬁed as never,ascular disease? An assessment of different deﬁnitions, Int J Cardiol
Table 1
clinical characteristics of the sample, by gender.
Women
(n=3241)
Men
(n=2929)
p-value
Age (years) 53.5±10.7 52.6±10.8 0.001
Body mass index (kg/m2) 25.1±4.8 26.6±4.0 b0.001
BMI status (%)
Normal 1860 (57.4) 1100 (37.6) b0.001
Overweight 917 (28.3) 1333 (45.5)
Obese 464 (14.3) 496 (16.9)
Smoking status (%)
Former 903 (27.9) 1129 (38.6) b0.001
Never 1529 (47.2) 944 (32.2)
Current 809 (24.9) 855 (29.2)
Systolic blood pressure (mm Hg) 125±18 132±17 b0.001
Diastolic blood pressure (mm Hg) 78±11 81±11 b0.001
Total cholesterol (mmol/L) 5.61±1.03 5.56±1.04 b0.05
HDL cholesterol (mmol/L) 1.81±0.43 1.44±0.36 b0.001
Fasting plasma glucose (mmol/L) 5.34±1.02 5.78±1.23 b0.001
Physical activity (%) § 1856 (57.3) 1567 (53.5) b0.001
Personal history of MI (%) 23 (0.7) 77 (2.6) b0.001
Baseline CVD (%) 167 (5.2) 230 (7.9) b0.001
2 A. Gabioud et al. / International Journal of Cardiology xxx (2012) xxx–xxxcurrent or former smokers. During a face-to-face meeting, the participants were asked
if they or their parents had presented CVD. Personal history of and current treatment
for hypertension, hypercholesterolemia or diabetes were also asked. Information on
the use of prescription and over the counter drugs, vitamin and mineral supplements,
homeopathy or natural remedies was collected, together with their main indications.
Collection was done by asking the participant to bring the drugs to the visit. Physical
activity was deﬁned as the practice of leisure time physical activity at least twice per
week.
Body weight and height were measured in light indoor clothes with shoes off. Body
weight was measured in kilograms to the nearest 100 g using a Seca® scale, which was
calibrated regularly. Height was measured to the nearest 5 mm using a Seca® height
gauge. Body mass index (BMI) was calculated as weight (kg) divided by the square
of the height (m). Overweight was deﬁned as BMI≥25 kg/m2 and b30 kg/m2, and obe-
sity by a BMI≥30 kg/m2.
Blood pressure was measured on the left arm, with an appropriately sized cuff,
after at least 10 min rest in the seated position using an Omron® HEM-907 automated
oscillometric sphygmomanometer. Three readings were taken and the average of the
last two was used to compute systolic (SBP) and diastolic (DBP) blood pressure.
Fasting plasma glucose and total cholesterol levels were measured by the CHUV
Clinical Laboratory on fresh blood samples within 2 h of blood collection. All measure-
ments were conducted in a Modular P apparatus (Roche Diagnostics, Switzerland). The
following analytical procedures (with maximum inter and intra-batch CVs) were used:
glucose by glucose dehydrogenase (2.1%–1.0%) and total cholesterol by CHOD-PAP
(1.6%–1.7%).Results are expressed as mean±standard deviation or as number of participants and
(percentage). § deﬁned as the practice of leisure time physical activity at least twice per
week. BMI, body mass index; CVD, cardiovascular disease; HDL, high density lipoprotein;
MI, myocardial infarction. Statistical analysis by Chi-square or Student's t-test.2.3. MONICA population surveys
The MONICA Project (Multinational MONItoring of trends and determinants in CArdio-
vascular disease) [13,14] was created in the early 1980s in different centers around the
world to monitor over a ten‐year period trends in cardiovascular disease mortality and inci-
dence. Thirty-one collaborating centers (25 from Europe, one from Canada, one from the US,
two from Australia, one from New Zealand and one from China) took part in the project. In
each population, investigators had to satisfy the local requirements for ethical research [14].
In this study, we used the data from the three Swiss MONICA population surveys
conducted in the Vaud and Fribourg cantons for the periods 1984–1986, 1988–1989
and 1992–1993. Their main characteristics have been published previously [15]. The
initial samples included participants aged between 25 and 75, but in order to be com-
parable with the CoLaus study we restricted the analysis to participants aged between
35 and 75 years.2.4. Risk factor assessment, MONICA
Body weight and height were measured with participants standing without shoes
and heavy outer garments and with empty pockets. Blood samples from non-fasting
subjects were used to measure the total cholesterol (TC). Smoking status was initially
divided in 4 categories, daily cigarette smokers, non smokers, ex-smokers and “differ-
ent types” of smokers (occasional, pipe, cigars). For the current analysis, daily and “dif-
ferent types” of smokers were grouped.
The authors of this manuscript have certiﬁed that they comply with the Principles
of Ethical Publishing in the International Journal of Cardiology [16].2.5. Low risk factor proﬁle
A literature search on Pubmed using the terms “low cardiovascular risk”, “low risk
factor”, “favorable risk factor” in association or not with the words “prevalence” and “ep-
idemiology” revealed eleven different deﬁnitions for low RF proﬁle [1–11]. Their criteria
are summarized in Supplementary Table 1. Three major CVD risk factors were common
to all deﬁnitions: blood pressure (SBPb120 and DBPb80 mm Hg); smoking (absence)
and total cholesterol (b200 mg/dL (b5.2 mmol/L)); for total cholesterol, only Yamamoto
used a different threshold: 160–240 mg/dL (4.14–6.22 mmol/L). Additional criteria dif-
fered according to each author. Most authors also included antihypertensive medication
(absence), personal history of diabetes (absence) and BMI (b25 kg/m2) in their criteria.
Three studies included electrocardiographic ﬁndings, two cholesterol lowering drug treat-
ment and one included personal history of myocardial infarction. Fasting plasma glucose
level was a criterion in one study and lifestyle (physical activity and diet) in another.
Overall, the number of criteria used to deﬁne low RF proﬁle varied between 4 and 11.
Noteworthy, a single author (Daviglus) used slightly different sets of criteria to deﬁne
low RF proﬁle [1,4,7,8] (Supplementary Table 1). The prevalence of low RF proﬁle in the
CoLaus cohort was computed using the following sets of criteria: Daviglus 2 [7] and 3
[4], Hozawa [5], Yamamoto [3], Giampaoli [2], Stamler [6] and Lowe [9] as they included
data available in the CoLaus study. The sets of criteria Daviglus 1 [1] and Daviglus 4 [8]
were not retained due to the lack of ECG data and the sets of criteria of Folsom [10] and
Mozaffarian [11] were not retained due to the lack of physical activity and dietary data.
Similarly, due to limitation in variables from theMONICA surveys, only two sets of criteria
were used to assess trends in the prevalence of low RF proﬁle: Lowe (SBPb120 mmHg,
DBPb80 mmHg, total cholesterolb200 mg/dL, no smoking) [9] and Daviglus 2
(SBPb120 mmHg, DBPb80 mmHg, total cholesterolb200 mg/dL, no smoking, no use of an-
tihypertensive medication, BMIb25 kg/m2) [7].Please cite this article as: Gabioud A, et al, Who is at low risk for cardiov
(2012), http://dx.doi.org/10.1016/j.ijcard.2012.07.0042.6. Statistical analysis
Statistical analyses were made using Stata v.11.1 (Stata Corp, College Station, TX, USA).
The prevalence of participants with low RF proﬁle was determined for each set of criteria
and expressed in percentage and (95% conﬁdence interval). Between-group comparisons
were performed using Chi-square for qualitative variables or Student's t-test for quantitative
variables.Multivariate analysismodeling the likelihoodof presentingwith lowRFproﬁlewas
conducted using logistic regression adjusting for gender, age and physical activity and the re-
sults were expressed as odds ratio (OR) and (95% conﬁdence interval). Standardized esti-
mates of the prevalence of low risk proﬁle were obtained by direct standardization using
the Standard European Population as deﬁned by [17]. Statistical signiﬁcance was considered
for pb0.05.
3. Results
3.1. Characteristics of the subjects
Of the initial 6188 participants, 6170 (99.7%, 3241 women and 2929
men)had data for all variables andwere included in the analysis. Table 1
summarizes their clinical characteristics according to gender. Overall,
women had a lower BMI, blood pressure and fasting plasma glucose
than men, women also smoked less, practiced more physical activity
andhad less history ofMI andCVD thanmen. Finally, womenhad higher
total and HDL cholesterol levels than men (Table 1).
3.2. Prevalence and trends of low risk factor proﬁle
The prevalence of low RF proﬁle overall and according to different
characteristics is summarized in Table 2.Women had a higher prevalence
of a low risk proﬁle; physical activity was positively associated with low
risk, while increasing age, family history of CVD, stroke or MI were asso-
ciatedwith a lower prevalence of low RF proﬁle. These ﬁndingswere fur-
ther conﬁrmed by multivariate logistic regression adjusting for gender,
age and leisure-time physical activity, where subjectswith a family histo-
ry of CVD (coronary heart disease or stroke) had a lower likelihood of
presenting with low RF proﬁle: odds-ratios (95% conﬁdence interval)
ranging from 0.76 (0.60–0.96) to 0.81 (0.62–1.04). The results were com-
parable (odds-ratio below 1) for coronary heart disease and stroke taken
individually, but did not reach statistical signiﬁcance (Table 3).
The trends in the prevalence of low RF proﬁle for period 1984–2006
are summarized in Table 4. The prevalence of low RF proﬁle remained
rather stable between 1984 and 1993 and increased afterwards. Interest-
ingly, the prevalence of low RF proﬁle in theMONICA studies showed theascular disease? An assessment of different deﬁnitions, Int J Cardiol
Table 2
Prevalence of low risk, by clinical characteristics.
Daviglus 2
[7]
Daviglus 3
[4]
Hozawa
[5]
Yamamoto
[3]
Giampaoli
[2]
Stamler
[6]
Lowe
[9]
Prevalence (%) 6.7
(6.1–7.3)
6.5
(5.9–7.1)
9.4
(8.7–10.2)
7.0
(6.4–7.7)
6.6
(6.0–7.2)
9.3
(8.5–10.0)
9.7
(9.0–10.5)
By gender (%)
Women 9.6
(8.6–10.6)
9.4
(8.4–10.4)
12.7
(11.6–13.9)
9.1
(8.1–10.1)
9.5
(8.5–10.5)
12.7
(11.5–13.8)
12.9
(11.8–14.1)
Men 3.5
(2.8–4.1)
3.2
(2.5–3.8)
5.7
(4.9–6.6)
4.8
(4.0–5.5)
3.4
(2.7–4.0)
5.5
(4.6–6.3)
6.1
(5.2–7.0)
p-value b0.001 b0.001 b0.001 b0.001 b0.001 b0.001 b0.001
By age group (%)
[35–44] 15.0
(13.3–16.7)
14.8
(13.1–16.5)
19.7
(17.8–21.6)
9.4
(8.0–10.7)
14.8
(13.1–16.5)
19.6
(17.8–21.5)
20.0
(18.2–21.9)
[45–54] 6.5
(5.4–7.7)
6.2
(5.1–7.3)
9.3
(8.0–10.7)
8.5
(7.2–9.8)
6.4
(5.3–7.6)
9.2
(7.8–10.5)
9.6
(8.2–10.9)
[55–64] 1.9
(1.2–2.5)
1.7
(1.0–2.3)
3.4
(2.5–4.3)
5.9
(4.8–7.0)
1.8
(1.2–2.5)
3.2
(2.3–4.0)
3.7
(2.8–4.5)
[65–75] 0.5
(0.1–0.10)
0.3
(0.0–0.7)
1.7
(0.8–2.5)
2.2
(1.2–3.1)
0.5
(0.1–1.0)
1.4
(0.1–2.2)
2.0
(1.1–2.8)
p-value b0.001 b0.001 b0.001 b0.001 b0.001 b0.001 b0.001
By physical activity (%)
No 5.2
(4.3–6.0)
5.0
(4.2–5.8)
8.0
(7.0–9.0)
5.1
(4.3–5.9)
5.1
(4.2–5.9)
7.8
(6.8–8.8)
8.4
(7.3–9.4)
Yes 7.9
(7.0–8.8)
7.6
(6.7–8.5)
10.6
(9.5–11.6)
8.6
(7.6–9.5)
7.8
(6.9–8.7)
10.4
(9.4–11.4)
10.7
(9.7–11.8)
P-value b0.001 b0.001 b0.002 b0.001 b0.001 b0.002 b0.005
By family history of CHD (%)
No 7.0
(6.3–7.8)
6.8
(6.1–7.5)
9.9
(9.1–10.7)
7.3
(6.5–8.0)
6.9
(6.2–7.6)
9.7
(8.9–10.6)
10.2
(9.4–11.1)
Yes 5.3
(4.1–6.6)
5.0
(3.8–6.2)
7.5
(6.1–9.0)
6.1
(4.8–7.4)
5.3
(4.1–6.6)
7.4
(5.9–8.8)
7.7
(6.2–9.2)
p-value b0.05 b0.05 b0.05 b0.20 b0.05 b0.01 b0.01
By family history of stroke (%)
No 7.1
(6.4–7.8)
6.9
(6.2–7.6)
10
(9.1–10.8)
7.1
(6.4–7.8)
7.0
(6.3–7.7)
9.8
(9.0–10.6)
10.2
(9.4–11.1)
Yes 4.4
(3.1–5.7)
4.0
(2.7–5.2)
6.5
(4.9–8.1)
6.5
(4.9–8.1)
4.4
(3.1–5.7)
6.3
(4.7–7.8)
6.7
(5.1–8.3)
P-value b0.005 b0.005 b0.005 b0.50 b0.005 b0.002 b0.002
By family history of CVD (%)
No 7.5
(6.6–8.3)
7.3
(6.5–8.1)
10.4
(9.5–11.4)
7.5
(6.7–8.3)
7.4
(6.6–8.1)
10.3
(9.4–11.2)
10.7
(9.8–11.7)
Yes 5.0
(4.1–6.0)
4.7
(3.8–5.6)
7.3
(6.2–8.5)
6.1
(5.1–7.2)
5.0
(4.1–6.0)
7.1
(6.0–8.3)
7.5
(6.4–8.7)
p-value b0.001 b0.001 b0.001 b0.06 b0.002 b0.001 b0.001
Results are expressed as percentage. Statistical analysis by Chi-square.
3A. Gabioud et al. / International Journal of Cardiology xxx (2012) xxx–xxxsame pattern of associations (higher in women and lower among older
participants).
In the CoLaus study, the prevalence of low RF inmen andwomenwas
higher than in the other studies (Table 5).
4. Discussion
To our knowledge, this is the ﬁrst ever study to compare the results of
different deﬁnitions of low RF proﬁle in the same population. Our resultsTable 3
multivariate analysis of the likelihood of presenting with a low cardiovascular risk factor p
Family history of Daviglus 2 Daviglus 3 Hozawa
Coronary heart disease 0.77
(0.58–1.02)
0.75
(0.56–1.00)
0.77
(0.60–0.97)
Stroke 0.78
(0.55–1.10)
0.73
(0.51–1.04)
0.79
(0.60–1.05)
Cardiovascular disease 0.77
(0.61–0.99)
0.74
(0.58–0.95)
0.79
(0.64–0.97)
Results are expressed as odds-ratio and (95% conﬁdence interval) for presence vs. absence of family
adjusting for gender, age and physical activity.
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(2012), http://dx.doi.org/10.1016/j.ijcard.2012.07.004suggest that the prevalence of lowRFproﬁle is rather lowanddepends on
the number of criteria used, as the two studies using the fewest criteria
(Lowe andHozawa) led to the highest prevalence. This is understandable,
as the probability of fulﬁlling all criteria decreases with the number of
criteria used. Still, and even more important than the number of criteria
used, the age of the participantwas themain factor to inﬂuence the prev-
alence of low RF proﬁle. This ﬁnding is in agreement with the literature
[18], as it has been shown that CVD risk increases with age, in association
with a decrease in the number of normal or optimal level RFs. Overall, ourroﬁle according to presence or absence of a family history of cardiovascular disease.
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0.81
(0.62–1.04)
0.79
(0.59–1.04)
0.76
(0.60–0.97)
0.76
(0.60–0.96)
0.95
(0.72–1.26)
0.80
(0.56–1.12)
0.78
(0.59–1.04)
0.79
(0.60–1.05)
0.82
(0.65–1.02)
0.79
(0.62–1.01)
0.78
(0.64–0.96)
0.79
(0.64–0.96)
history. Statistical analysis conducted independently for each condition by logistic regression
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Table 4
Evolution of the prevalence of low risk proﬁle in several population-based studies in Switzerland, 1984–2006.
Daviglus 2 Lowe
1984–1986 1988–1989 1992–1993 2003–2006 1984–1986 1988–1989 1992–1993 2003–2006
Prevalence (%) 3.8
(3.1–4.5)
3.3
(2.6–3.9)
3.7
(3.0–4.4)
6.7
(6.1–7.3)
5.9
(5.1–6.8)
4.4
(3.7–5.2)
5.0
(4.2–5.8)
9.7
(9.0–10.5)
By gender (%)
Women 6.1
(4.9–7.4)
5.1
(3.9–6.2)
5.9
(4.6–7.1)
9.6
(8.6–10.6)
8.5
(7.1–10.0)
6.3
(5.0–7.6)
7.6
(6.2–8.9)
12.9
(11.8–14.1)
Men 1.5
(0.9–2.1)
1.6
(0.9–2.2)
1.4
(0.7–2.0)
3.5
(2.8–4.1)
3.4
(2.5–4.3)
2.6
(1.8–3.5)
2.3
(1.5–3.1)
6.1
(5.2–7.0)
By age group (%)
[35–44] 7.0
(5.5–8.5)
6.8
(5.2–8.4)
7.6
(6.0–9.3)
15.0
(13.3–16.7)
10.7
(8.9–12.5)
8.7
(7.0–10.5)
9.7
(7.8–11.6)
20.0
(18.2–21.9)
[45–54] 2.6
(1.5–3.6)
2.2
(1.2–3.1)
2.6
(1.6–3.7)
6.5
(5.4–7.7)
4.3
(3.0–5.7)
3.5
(2.3–4.7)
3.9
(2.7–5.2)
9.5
(8.2–10.9)
[55–64] 1.3
(0.5–2.2)
0.6
(0.0–1.1)
0.3
(0.0–0.7)
1.9
(1.2–2.5)
2.2
(1.1–3.3)
0.8
(0.2–1.5)
0.7
(0.1–1.4)
3.6
(2.8–4.5)
[65–75] 0.0 0.4
(0.0–1.3)
0.5
(0.0–1.6)
0.5
(0.1–1.0)
0.0 0.4
(0.0–1.3)
1.1
(0.0–2.6)
2.0
(1.1–2.8)
Standardized prevalence 3.2
(2.3–4.2)
2.9
(1.9–4.0)
3.3
(2.3–4.4)
7.1
(6.0–8.2)
5.1
(3.9–6.3)
4.0
(2.9–5.2)
4.5
(3.1–5.8)
10.1
(8.9–11.5)
Results are expressed as percentage and (95% conﬁdence interval). The standardized prevalence of low risk proﬁle was obtained by direct standardization using the Standard
European Population as deﬁned by [17].
4 A. Gabioud et al. / International Journal of Cardiology xxx (2012) xxx–xxxresults indicate that the more criteria to deﬁne low RF proﬁle or the
higher the age of the participants, the lower the prevalence of low RF
proﬁle.
The prevalence of low RF proﬁle was higher in CoLaus than in the
other studies. Only the studies by Daviglus (set 3) [4] and Yamamoto
[3] had a higher prevalence of low RF proﬁle among women. This ﬁnd-
ing can be explained by the younger age of the participants in both sur-
veys: in the American study, mean (±SD) agewas 31.0±1.3 years, vs.
53.5±10.7 years in the CoLaus study; in the Japanese study, the age
range was 30–69 years, vs. 35–75 years in the CoLaus study. Interest-
ingly, restricting the analysis in the CoLaus study to the 30–69 years age
group led to a higher prevalence of low RF proﬁle in women (9.7%) albeit
lower than in the Japanese study. One possible explanation might be re-
lated to the fact that Asians tend to present with lower BMI levels [19]
and probably also with a lower prevalence of CVD risk factors. Overall,
our results indicate that, compared to other studies, the prevalence of
low RF proﬁle is relatively high in this Swiss population-based sample.
This high prevalence of low RF proﬁle among the Swiss might partly ex-
plain the low CVD mortality rates observed in Switzerland relative to
the other countries [20].
The trends in the prevalence of low RF proﬁle in the Swiss population
were assessed using data from the MONICA population studies and theTable 5
Comparison of the prevalence of low risk factor proﬁle between the current study and othe
Daviglus 2 Daviglus 3 Hozawa
Prevalence this study (%)
Overall 6.7
(6.1–7.3)
6.5
(5.9–7.1)
9.4
(8.7–10.2
Women 9.6
(8.6–10.6)
9.4
(8.4–10.4)
12.7
(11.6–13.
Men 3.5
(2.8–4.1)
3.2
(2.5–3.8)
5.7
(4.9–6.6
Prevalence original study (%)
Period of inclusion 1967–1973 1967–1973 1987–198
Age range (years) 40–59 18–39 45–64
Women 4.7 20.1 6.5
Men 2.0 4.6
§ Pooled data from two cohorts.
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(2012), http://dx.doi.org/10.1016/j.ijcard.2012.07.004criteria of Daviglus (set 2) [7] and Lowe [9]. The results suggest that
the prevalence of low RF proﬁle was stable between 1984 and 1993
and increased afterwards (Table 4). This favorable change could be
due to changes in a single or several risk factor(s), such as smoking (in-
crease in the nineties and decrease afterwards) [21], physical activity
(increase) [22] or the maintenance of a relatively healthy diet [23]. In-
deed, in the CoLaus study, the prevalence of low RF proﬁle was higher
among participants who practiced leisure physical activity; conversely,
no dietary data were available to conﬁrm the last hypothesis. Finally,
this increase in the prevalence of low RF proﬁle is in agreement with
the decrease in CVDmortality rates observed in Switzerland [24]. Overall,
our results indicate that the prevalence of low RF proﬁle is increasing in
Switzerland, and that this increase could be due to changes in several
RF such as smoking or physical activity, or the maintenance of a healthy
diet.
Participants with a family history of cardiovascular disease had a
lower likelihood of presenting with a low RF proﬁle. This ﬁnding was
further conﬁrmed by multivariate adjustment, although the association
did not reach statistical signiﬁcance for coronary heart disease or stroke
taken individually, probably due to the small sample size. This ﬁnding
could partly be explained by worse dietary behaviors or a particular ge-
netic background. The existence of a large genetic database for most ofr studies, using the same criteria to deﬁne low risk proﬁle.
Yamamoto Giampaoli Stamler Lowe
)
7.0
(6.4–7.7)
6.6
(6.0–7.2)
9.3
(8.5–10.0)
9.7
(9.0–10.5)
9)
9.1
(8.1–10.1)
9.5
(8.5–10.5)
12.7
(11.5–13.8)
12.9
(11.8–14.1)
)
4.8
(4.0–5.5)
3.4
(2.7–4.0)
5.5
(4.6–6.3)
6.1
(5.2–7.0)
9 1980 1983–1997 1967–1975 1967–1973
30–69 35–69 35–59§ 40–64
14.4 3.5 6.6
3.0 1.6 4.8
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(which also includes dietary assessment) will allow a better assessment
of these hypotheses.
This study has some limitations. First, generalizationmight be limited
by the modest participation rate (41%), but this rate is comparable to
other epidemiological studies [25]. Second, it is possible that the CoLaus
participants are more health-conscious than the general population,
thus biasing the observed prevalence of the low RF proﬁle to higher
than actual values; still, all studies which assessed low RF proﬁle did
so using volunteers, so this overestimation bias also applies to them.
Third, the CoLaus study only included Caucasian participants, and it
has been suggested that the prevalence of low RF proﬁle is higher in
non-Caucasian populations [5,26]. Still, most studies which assessed
low RF proﬁle included mostly white, Caucasian participants [2,6],
with the exception of Daviglus [1,4,7,8], Folsom [10] and Lowe [9], so
comparison of our results with these studies can still be performed. Fi-
nally, it might be questioned whether the CoLaus study is representative
of the Swiss population; still, a considerable fraction of the Lausanne in-
habitants are actually not native to the Vaud canton: in 2006, out of the
128 231 Lausanne inhabitants, 49 330 (38%) were non-Swiss, 38 513
(30%) came from other cantons, and only 40 388 subjects (32%) were
from the Vaud canton. Hence, we do believe that the CoLaus study repre-
sents a fairly good sample of the Swiss population. Finally, as the CoLaus
study only included participants aged between 35 and 75, the prevalence
rates provided only apply to the population within this age range. As the
prevalence of low risk proﬁle is dependent on age, younger or older age
groups would have higher and lower prevalence rates, respectively.
5. Conclusion
Our results indicate that, in a given population, the prevalence of low
cardiovascular risk factor proﬁle varies according to the criteria used.
Compared to other countries, the prevalence of low cardiovascular risk
factor proﬁle is relatively high and increasing in the Swiss population,
whichmight partly explain the low and decreasing trend in cardiovascu-
lar mortality rates.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ijcard.2012.07.004.
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